ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022
Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022.
Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Dynamics of global mpox epidemics, 1970-2025: a systematic review and meta-analysis of evolving transmissibility and intervention effects.BMJ global health · 2026Pooled it
- Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022-2023 global outbreak.BMJ global health · 2025Pooled it
- Modeling the 2022 mpox outbreak with a mechanistic network model.BMC infectious diseases · 2025Article
- Global transmission characteristics of mpox outbreaks: a systematic review and meta-analysis.EClinicalMedicine · 2025Article
- Considering the effects of pair formation dynamics on mpox and HIV co-infection in the gbMSM community.Scientific reports · 2025Article
- Evaluating the effectiveness of international travel controls to identify MPXV-infected travelers: a simulation study.BMC medicine · 2025Article
- Transmission Dynamics of Mpox in Peru During the 2022 Outbreak.The American journal of tropical medicine and hygiene · 2025Article
- Targeted vaccination is effective for mpox clade Ib in England despite increased household transmission: Predictions from a modelling study.PLOS global public health · 2025Article
- The risk of mpox importation and subsequent outbreak potential in Chinese mainland: a retrospective statistical modelling study.Infectious diseases of poverty · 2024Article
- ASSESSING THE KNOWLEDGE OF SMALLPOX AND MONKEYPOX VIRUS AMONG THE UNIVERSITY OF TLEMCEN MEMBERS IN THE WAKE OF COVID-19: A 2023 CROSS-SECTIONAL STUDY.African journal of infectious diseases · 2024Article
- Estimates of mpox effective reproduction number in Spain, April-August 2022.Epidemiology and infection · 2023Article
- Clinical and Epidemiological Interventions for Monkeypox Management in Children: A Systematic Review.Cureus · 2023Review
- Transmission of monkeypox/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak.Journal of medical virology · 2023Review
- Monkeypox.Lancet (London, England) · 2023Review
- Human Monkeypox-A Global Public Health Emergency.International journal of environmental research and public health · 2022Review
- Monkeypox infection: An update for the practicing physician.European journal of internal medicine · 2022Review
- Early estimates of the incidence trend and the reproductive number of the monkeypox epidemic in Brazil.Travel medicine and infectious diseaseArticle
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo estimate the basic reproductive number (Ro) to help us understand and control the spread of monkeypox in immunologically naive populations.
methodsUsing three highest incidence populations including England, Portugal, and Spain as examples as of 18 June 2022, we employed the branching process with a Poisson likelihood and gamma-distributed serial interval to fit daily reported case data of monkeypox to estimate Ro. Sensitivity analyses were performed by varying mean serial interval from 6.8 to 12.8 days.
resultsThe median posterior estimates of Ro for monkeypox in the three study populations were statistically >1 (England: Ro = 1.60 [95% (credible interval) CrI, 1.50-1.70]; Portugal: Ro = 1.40 [95% CrI, 1.20-1.60]; Spain: Ro = 1.80 [95% CrI, 1.70-2.00]). Ro estimates varied over 1.30 to 2.10, depending on the serial interval. DISCUSSION: The updated Ro estimates across different populations will inform policy makers' plans for public health control measures. Currently, monkeypox has a sustainable outbreak potential and may challenge healthcare systems, mainly due to declines in the population level immunity to Orthopoxviruses since the cessation of routine smallpox vaccination. Smallpox vaccination has been shown to be effective in protecting (≤85% effectiveness) against monkeypox infection in earlier times. So early postexposure vaccination is currently being offered in an attempt to control its spread.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.